Chronic hepatitis B
Open Access
- 29 November 2005
- journal article
- other
- Published by Wolters Kluwer Health in Hepatology
- Vol. 42 (6) , 1459
- https://doi.org/10.1002/hep.20951
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis BNew England Journal of Medicine, 2005
- Long‐term follow‐up of peginterferon and lamivudine combination treatment in HBeAg‐positive chronic hepatitis B†Hepatology, 2005
- New perspectives in the treatment of HBeAg‐positive and HBeAg‐negative chronic hepatitis B†Hepatology, 2005
- Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trialThe Lancet, 2005
- Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis BNew England Journal of Medicine, 2004
- A phase II dose-escalating trial of clevudine in patients with chronic hepatitis BHepatology, 2004
- ReplyGastroenterology, 2004
- Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis BHepatology, 2004
- Long-term safety of lamivudine treatment in patients with chronic hepatitis BGastroenterology, 2003
- Extended Lamivudine Treatment in Patients With Chronic Hepatitis B Enhances Hepatitis B E Antigen Seroconversion Rates: Results After 3 Years of TherapyHepatology, 2001